|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2024―Aug―15 |
The Healthcare Study Examines the Humoral Anti-S1 Antibody Response Following mRNA Vaccination, Comparing Individuals with and without Prior SARS-CoV-2 Infection |
Małgorzata Staruszkiewicz, Anna Pituch-Noworolska, Mohamad Skayne, Torsten Matthias, Szymon Skoczen |
2 |
[GO] |
2024―Jan―04 |
Mechanisms of SARS-CoV-2 Placental Transmission |
Karol Gostomczyk, Jędrzej Borowczak, Marta Siekielska-Domanowska, Krzysztof Szczerbowski, Mateusz Maniewski, Mariusz Dubiel, et al. (+2) Łukasz Szylberg, Magdalena Bodnar |
3 |
[GO] |
2023―Jun―21 |
Are Measles-Mumps-Rubella (MMR) Antibodies Friends or Foes for Covid-19 Disease? |
Azza Salamony, Yara Shamikh, Khaled Amer, Tarek Elnagdy, Mostafa Elnakib, Abd Allah Yehia, et al. (+2) Wael Hassan, Maha Abdelsalam |
4 |
[GO] |
2023―Mar―02 |
The Effects of Statins on Respiratory Symptoms and Pulmonary Fibrosis in COVID-19 Patients with Diabetes Mellitus: A Longitudinal Multicenter Study |
Mohammadamin Sadeghdoust, Farnaz Aligolighasemabadi, Tania Dehesh, Nima Taefehshokr, Adel Sadeghdoust, Katarzyna Kotfis, et al. (+9) Amirhossein Hashemiattar, Amir Ravandi, Neda Aligolighasemabadi, Omid Vakili, Beniamin Grabarek, Rafał Staszkiewicz, Marek J. Łos, Pooneh Mokarram, Saeid Ghavami |
5 |
[GO] |
2023―Feb―21 |
Immunity in SARS-CoV-2 Infection: Clarity or Mystery? A Broader Perspective in the Third Year of a Worldwide Pandemic |
Katarzyna Kapten, Krzysztof Orczyk, Elzbieta Smolewska |
6 |
[GO] |
2022―Aug―03 |
Elevated Levels of Soluble CD147 are Associated with Hyperinflammation and Disease Severity in COVID-19: A Proof-of-Concept Clinical Study |
Rashidi Springall, Julieta González-Flores, Carlos García-Ávila, Yaneli Juárez-Vicuña, Adrián Hernández-Diazcouder, Ricardo Márquez-Velasco, et al. (+11) Sergio Cásares-Alvarado, Fausto Sánchez-Muñoz, Edna Basilio-Gálvez, Mauricio Castillo-Salazar, Martha A. Ballinas-Verdugo, Malinalli Brianza-Padilla, José L. Sánchez-Gloria, Claudia Tavera-Alonso, Julio Sandoval, Héctor González-Pacheco, Luis M. Amezcua-Guerra |
7 |
[GO] |
2022―Mar―24 |
Preliminary Results for Personalized Therapy in Pregnant Women with Polycystic Ovary Syndrome During the COVID-19 Pandemic |
Małgorzata Jerzak, Monika Szafarowska |
8 |
[GO] |
2021―Sep―16 |
Are Host Defense Peptides and Their Derivatives Ready to be Part of the Treatment of the Next Coronavirus Pandemic? |
Bruno Rivas-Santiago, Yolanda Jacobo-Delgado, Adrian Rodriguez-Carlos |
9 |
[GO] |
2021―Mar―06 |
The Potential of Developing Pan-Coronaviral Antibodies to Spike Peptides in Convalescent COVID-19 Patients |
Andrii Rabets, Galyna Bila, Roman Grytsko, Markian Samborskyy, Yuriy Rebets, Sandor G. Vari, et al. (+5) Quentin Pagneux, Alexandre Barras, Rabah Boukherroub, Sabine Szunerits, Rostyslav Bilyy |
10 |
[GO] |
2021―Feb―02 |
DPP4 Inhibitors and COVID-19-Holy Grail or Another Dead End? |
Alicja Krejner-Bienias, Katarzyna Grzela, Tomasz Grzela |
11 |
[GO] |
2020―Nov―13 |
SARS-CoV-2: Remarks on the COVID-19 Pandemic |
Egbert Piasecki |